We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVC
476
Service Properties Trust
SVC
$1.1B
| $3.23M | 0.02% |
21,718
+40
| +0.2% | +$6.1K |
|
477
AGCO
AGCO
$8.78B
| $3.21M | 0.02% |
65,002
-245,754
| -79% | -$11.8M |
|
478
Vanguard Growth ETF
VUG
$216B
| $3.18M | 0.02% |
169,878
+29,532
| +21% | +$549K |
|
|
SCLN
479
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $3.13M | 0.02% |
305,073
| – | – |
|
480
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $3.1M | 0.02% |
20,799
| – | – |
|
481
Citigroup
C
$222B
| $3.09M | 0.02% |
65,446
-9,363
| -13% | -$426K |
|
|
TEP
482
DELISTED
Tallgrass Energy Partners, LP
TEP
| $3.08M | 0.02% |
63,841
-4,806
| -7% | -$224K |
|
|
PRXL
483
DELISTED
Parexel International Corp
PRXL
| $3.06M | 0.02% |
44,060
-2,470
| -5% | -$167K |
|
|
NCI
484
DELISTED
Navigant Consulting, Inc.
NCI
| $3.03M | 0.02% |
150,022
+62
| +0% | +$1.18K |
|
485
American Tower
AMT
$77.7B
| $3.03M | 0.02% |
26,762
+535
| +2% | +$61.2K |
|
486
Honda
HMC
$36.5B
| $2.98M | 0.02% |
103,149
+96,558
| +1,465% | +$2.76M |
|
487
Revvity
RVTY
$12.3B
| $2.94M | 0.02% |
52,420
-4,064
| -7% | -$222K |
|
488
Lincoln National
LNC
$7.91B
| $2.91M | 0.02% |
61,991
-3,647
| -6% | -$163K |
|
|
GOV
489
DELISTED
Government Properties Income Trust
GOV
| $2.88M | 0.02% |
127,100
| – | – |
|
490
KBR
KBR
$4.68B
| $2.87M | 0.02% |
189,780
| – | – |
|
491
Nabors Industries
NBR
$1.23B
| $2.85M | 0.02% |
4,693
+887
| +23% | +$437K |
|
492
Children's Place
PLCE
$53.6M
| $2.84M | 0.02% |
35,528
+4,702
| +15% | +$387K |
|
|
HEP
493
DELISTED
Holly Energy Partners, L.P.
HEP
| $2.81M | 0.02% |
82,707
+12,850
| +18% | +$436K |
|
|
MJN
494
DELISTED
Mead Johnson Nutrition Company
MJN
| $2.8M | 0.02% |
35,482
-10,047
| -22% | -$857K |
|
495
Teradyne
TER
$54.8B
| $2.8M | 0.02% |
129,930
-9,902
| -7% | -$204K |
|
496
BP
BP
$113B
| $2.8M | 0.02% |
94,658
-740
| -0.8% | -$21.5K |
|
497
Cencora
COR
$60.3B
| $2.77M | 0.02% |
34,249
-242
| -0.7% | -$20.7K |
|
|
CVG
498
DELISTED
Convergys
CVG
| $2.75M | 0.02% |
90,475
+21,130
| +30% | +$599K |
|
499
iShares Russell 2000 Value ETF
IWN
$14.4B
| $2.75M | 0.02% |
26,262
-9,115
| -26% | -$934K |
|
500
Edwards Lifesciences
EW
$47.6B
| $2.75M | 0.02% |
68,364
-17,481
| -20% | -$658K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.